“The experience with the pandemic has taught us that collaboration at various levels is essential to make the machine work better: on the one hand to govern it, on the other hand to ensure concrete accessibility to innovation by citizens. of the economic resources aspect, the fact that too many times we risk that there is a difference between the Regions in terms of access to innovative drugs is no longer acceptable. We must find a way to overcome a model that for too long has been a ‘defense’ of its own areas and prerogatives and which has not always led to better system functionality.“He said it Antonio GaudiosoHead of the Secretariat of the Ministry of Health, speaking in the afternoon at the webinar-round table ‘Fund for innovative drugs and Fund for rare diseases’, promoted and organized by Helaglobe.
An opportunity to present Synthesisthe first appointment for the sharing of a Position Paper on the Innovative Medicines Fund and the Rare Diseases Fund which sees the involvement of the managers of the regional drug policies of Campania, Emilia Romagna, Liguria, Lazio, Lombardy and Tuscany.
“Aifa, Regions, Ministry of Health and Mef: each of us has a role – added Gaudioso – but tall of us must be facilitators, we must discuss and reason together on every single proposal, favor the exchange of information, work on the management of flows. We must use the tools we have appropriately, among which there is certainly the Aifa 5% National Fund, with an approach of simplification, facilitation and problem solving “.